Myocardial Infarction Market Size Report Predicts Healthy Growth with Demand & Forecasts by 2031

The global myocardial infarction market is anticipated to grow at a CAGR of around 6.6% during the forecast period (2024-2031). Factors contributing to the growth of the myocardial infarction market include rising incidence rate of CVDs (cardiovascular diseases) and intake of high-level sugary food, which significantly boost the prevalence of CADs (coronary artery diseases). According to the American Heart Association estimates, CVD is the leading global cause of death and accounted for approximately 18.6 million deaths in 2019. Further, according to WHO, CVDs are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. 4 out of 5 CVD deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age. Due to the rising prevalence of cardiovascular disease which is the leading cause of mortality, the demand for early detection technologies and diagnostic methods such as ECG, CT-Scan, Echocardiography is increasing, which further driving the market growth.

Get Free Sample link @ https://www.omrglobal.com/request-sample/myocardial-infarction-market

Apart from this, the major market players are also taking initiatives by adopting various strategies such as mergers and acquisitions to expand their product offering and launching new technologies to fulfil the demands of the market and healthcare sector. For instance, in October 2020, Abbott had launched next-generation heart rhythm management devices, the Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) in India. The devices are used for people with abnormal heart rhythms and heart failure. Both the devices offer patient engagement and remote monitoring through smartphone connectivity and connected applications. Moreover, in Jan 2021, Boston Scientific has announced the acquisition of Preventice Solutions, Inc, which offers a full portfolio of mobile cardiac health solutions and services. The acquisition was under a definitive agreement of $925 million. The acquisition will aid Boston Scientific to expand its position in the high-growth ambulatory electrocardiography space, and further help to enter into the implantable cardiac monitor market to expand its cardiac diagnostics and services. Thus, such type of strategies adopted by key players is expected to enhance the market prospects for further growth and developments.

Full report of Myocardial Infarction Market available @ https://www.omrglobal.com/industry-reports/myocardial-infarction-market

Market Coverage

Segment Covered-
o By Type

o By Device

o By Diagnosis

o By Treatment

o By End-User

Regions Covered-
o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Koninklijke Philips N.V., Abbott Laboratories, Siemens AG, Bayer AG, Novartis AG, Boehringer Ingelheim GmbH, AstraZeneca PLC, Merck KGaA, Sanofi SA, Pfizer Inc., GSK PLC, Johnson & Johnson Services Inc., Mylan N.V., among others.

Key questions addressed by the report:

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Myocardial Infarction Market Report Segment

By Type

Non-St-Elevation Myocardial Infarction (NSTEMI)
St-Elevation Myocardial Infarction (STEMI) Heart Attack
Silent Heart Attack

By Device

Left Ventricular Assist Device
Pacemaker
Catheters
Implantable Cardioverter Defibrillator
Others

By Diagnosis

Electrocardiography (ECG)
Chest X-Ray
Computed Tomography (Ct Scan)
Echocardiography
Others

By Treatment

Medication
o Analgesics

o Thrombolytic

o Anti-Platelet Agents

o Glycoprotein LIB/LIB Inhibitors

o Others (Beta-Adrenergic Blockers and Angiotensin-Receptor Blockers)

Surgery
o Angioplasty

o CABG

o Heart Transplant

By End-Users

Hospitals and Clinics
Ambulatory Surgical Centers
Research Institutes


Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/myocardial-infarction-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.